Coinspeaker Dow Futures Rise as Novavax Reports Its Progress in COVID-19 Vaccine DevelopmentAmerican biotech company Novavax said it had started the first human study of its experimental coronavirus vaccine, with initial results on safety and immune responses expected in July. The U.S. futures positively reacted to the news.Dow Futures Rise as Novavax Reports Its Progress in COVID-19 Vaccine Development
